FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Biotech Venture Capital | Ambrx

Ambrx garners $10M in new funds

La Jolla, CA-based Ambrx has raised $10 million in new venture funds, adding to the $70 million it has already raised from the likes of 5AM Ventures and Aravis and Versant. Ambrx has been developing a novel protein modification platform. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Biotech Venture Capital   Ambrx